StonvexLoading…
StonvexStonvexStonvexCore line items from TRN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-29 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Annual 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $503.33M | $492.00M | $2.16B | $454.10M | $506.20M |
Operating Income | Not available | $101.10M | $649.20M | $118.60M | $95.40M |
Net Income | Not available | $24.20M | $253.10M | $30.30M | $14.10M |
EPS (Diluted) | $1.37 | $0.30 | $3.05 | $0.37 | $0.17 |
Total Assets | Not available | $8.33B | $8.42B | $8.93B | $8.81B |
Total Liabilities | Not available | $7.18B | $7.28B | $7.68B | $7.55B |
Cash & Equivalents | Not available | $132.60M | $201.30M | $66.30M | $147.70M |
Free Cash Flow OCF − CapEx | Not available | $91.50M | $314.10M | $155.50M | $120.20M |
Shares Outstanding | Not available | 81.90M | 82.90M | 83.10M | 83.40M |